Are you interested in Sync? Submit your contact info here or click the "Contact me about Sync" button below and we will reach out to you with more information.
GLP-1 Weight-Loss Boom Linked to Surge in Poison Control Calls
A new study found that calls to poison control centers involving popular GLP-1 weight-loss drugs climbed sharply after semaglutide was approved for obesity in 2021, with most cases linked to medication mistakes that could have been avoided.
Health News is provided as a service to Southpointe Pharmacy site users by HealthDay. Southpointe Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.